←  BACK TO NAH MASTER CLASS

Educational Goals

This course will focus on patient assessment and will address the wide national and international variation in elements of psychosocial assessment that may potentially impact decision-making around candidacy for MCS or transplantation. Also covered will be the wide variation across centers in how psychosocial evaluation information is used in making these candidacy transition decisions. The course will also focus on the role of the patient’s family/caregivers and how they are often underrecognized participants in care and how advanced planning support and end-of-life care is not consistently provided.

Target Audience

The Nursing and Allied Health Master class is designed for clinicians from all fields of the interdisciplinary health team with a higher level of expertise in transplant and/or MCS. The program format is intended to facilitate highly interactive discussion amongst the participants in order to explore topics relating to significant transitions in care for patients and their family members/caregivers facing transplantation, MCS or end-of-life discussion. Rather than didactic lectures, this course will utilize faculty moderators and case discussants to present real-world case scenarios to stimulate active audience participation, providing insights, strategies and skills that will address the practice gaps and learning objectives.

Learning Objectives

At the conclusion of this meeting, participants will have improved competence and professional performance in their ability to:
 

1. Describe the key elements recommended for psychosocial assessment for transplant or MCS.
2. Recognize what influences our decision-making when determining candidacy for transplant or MCS.
3. Provide insights and solutions to manage patients’ psychosocial challenges discovered during the screening process to support candidates to achieve maximum success in transplantation or MCS.
4. Address risk factors in order to optimize patient candidacy for transplantation or MCS.
5. Identify and describe strategies and mechanisms to engage family members/care givers in patient care and decision-making.
6. Incorporate strategies for advance care planning and end-of-life care into routine clinical practice.

Accreditation & Credit Designation Statements

Physicians
The International Society for Heart & Lung Transplantation (ISHLT) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ISHLT designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credit(s)™ (each Academy is 4.50 AMA PRA Category 1 Credits(s)™). Two Academies can be attended on April 18, 2023 for a maximum of 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and International Society for Heart & Lung Transplantation. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nurses and Pharmacists
Amedco LLC designates this activity for a maximum of 9.00 ANCC contact hours (each Academy has 4.50 ANCC contact hours). in the activity.

Pharmacists (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 9.00 knowledge-based CPE contact hours. (Each Academy has 4.50 knowledge-based CPE contact hours).

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.